Mike Grady
Mike Grady publishes mostly in Endocrinology, Diabetes and Metabolism, General Health Professions and Biomedical Engineering, on topics such as Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients and Diabetes Management and Education.
- World rank
- #4,715,976 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #288,825 of 367,258
- Works
- 61
- Citations
- 643
- Citations per work
- 10.5
What does Mike Grady research?
Mike Grady's work is mostly in Medicine (62%), Health Professions (14%), Engineering (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4675.7%
- Medicine3861.6%
- Health Professions914.1%
- Everything else915.3%
- Physical Sciences46.4%
- Engineering46.4%
- Life Sciences22.6%
- 1Endocrinology, Diabetes and Metabolism59% of their works
- 2General Health Professions14% of their works
- 3Biomedical Engineering3% of their works
- 4Electrical and Electronic Engineering3% of their works
- 5Surgery3% of their works
- 6Genetics3% of their works
Research topics
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
- Mobile Health and mHealth Applications
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Electrochemical sensors and biosensors
- Diabetes and associated disorders
- Pancreatic function and diabetes
Which keywords describe Mike Grady's research?
The keywords of their largest research topics: Glycemic Control, Diabetes, Insulin Therapy, Cardiovascular Disease, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Diabetes Mellitus.
- ß-Cell Dysfunction
- Genetics
- Graphene
- Metabolic Syndrome
- mHealth
- Self-Management
- Hyperglycemia
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Cardiovascular Disease
- Diabetes
- Glycemic Control
- Insulin Therapy
- Type 1 Diabetes
- Hypoglycemia
- Critical Care
- Depression
- Mobile Health
- Insulin Resistance
- Electrochemical Biosensors
- Autoimmunity
- Pancreatic Islets
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycemic Control833 topics
- Diabetes673 topics
- Insulin Therapy632 topics
- Cardiovascular Disease472 topics
- Type 1 Diabetes442 topics
- Continuous Glucose Monitoring401 topic
- Hypoglycemia401 topic
- Diabetes Mellitus272 topics
- Critical Care231 topic
- Hyperglycemia231 topic
- Depression201 topic
- Self-Management201 topic
- Mobile Health181 topic
- mHealth181 topic
- Insulin Resistance71 topic
- Metabolic Syndrome71 topic
- Electrochemical Biosensors51 topic
- Graphene51 topic
- Autoimmunity41 topic
- Genetics41 topic
- Pancreatic Islets41 topic
- ß-Cell Dysfunction41 topic
Where does Mike Grady work?
Mike Grady's main affiliation in the publication record is NovaBiotics (United Kingdom), United Kingdom.
How many publications and citations does Mike Grady have?
OpenAlex counts 61 works and 643 citations for Mike Grady, an h-index of 14, ranking #4,715,976 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mike Grady. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.